US Patent

US8236861 — Method for enhancing the bioavailablity of ospemifene

Method of Use · Assigned to Hormos Medical Corp · Expires 2026-08-11 · 0y remaining

Vulnerability score 85/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a method for increasing the effectiveness of a specific type of medication when taken orally with food.

USPTO Abstract

This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Drugs covered by this patent

Osphena (OSPEMIFENE) · Duchesnay

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-905`	—	Osphena

Patent Metadata

Patent number: US8236861
Jurisdiction: US
Classification: Method of Use
Expires: 2026-08-11
Drug substance claim: No
Drug product claim: No
Assignee: Hormos Medical Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.